The Role of Node Dissection for Thyroid Cancer

      Regional lymph node metastases are common in patients with thyroid cancer.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Advances in Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Lim H.
        • Devesa S.S.
        • Sosa J.A.
        • et al.
        Trends in thyroid cancer incidence and mortality in the United States, 1974-2013.
        JAMA. 2017; 317: 1338-1348
        • Siegel R.L.
        • Miller K.D.
        • Jemal A.
        Cancer statistics, 2020.
        CA Cancer J Clin. 2020; 70: 7-30
        • Randle R.W.
        • Rosen J.E.
        Thyroid cancer mortality in an aging population.
        Bull Am Coll Surg. 2019; 104: 37-40
        • Stulak J.M.
        • Grant C.S.
        • Farley D.R.
        • et al.
        Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer.
        Arch Surg. 2006; 141 ([discussion 494-6]): 489-494
        • Randle R.W.
        • Balentine C.J.
        • Leverson G.E.
        • et al.
        Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years.
        Surgery. 2017; 161: 137-146
        • Kloos R.T.
        • Eng C.
        • et al.
        • American Thyroid Association Guidelines Task Force
        Medullary thyroid cancer: management guidelines of the American Thyroid Association.
        Thyroid. 2009; 19: 565-612
      1. Ghanem M, Olson MT, Zeiger MA. Approach to thyroid nodules. In: Textbook of Endocrine Surgery: 3rd edition. In: Clark OH, Duh QY, Kebebew E, Gosnell JE, Shen WT, editors. Jaypee Brothers Medical Publishers; 2016. p. 121–30.

        • Schmid D.
        • Ricci C.
        • Behrens G.
        • et al.
        Adiposity and risk of thyroid cancer: a systematic review and meta-analysis.
        Obes Rev. 2015; 16: 1042-1054
        • Bates M.F.
        • Lamas M.R.
        • Randle R.W.
        • et al.
        Back so soon? Is early recurrence of papillary thyroid cancer really just persistent disease?.
        Surgery. 2018; 163: 118-123
        • Kim H.K.
        • Ha E.J.
        • Han M.
        • et al.
        Reoperations for structurally persistent or recurrent disease after thyroidectomy.
        Sci Rep. 2020; 10: 12376
        • McDow A.D.
        • Shumway C.M.
        • Pitt S.C.
        • et al.
        Utility of early postoperative unstimulated thyroglobulin in influencing decision making in patients with papillary thyroid carcinoma.
        Ann Surg Oncol. 2019; 26: 4002-4007
        • Randle R.W.
        • Bates M.F.
        • Schneider D.F.
        • et al.
        Survival in patients with medullary thyroid cancer after less than the recommended initial operation.
        J Surg Oncol. 2018; 117: 1211-1216
        • Haugen B.R.
        • Alexander E.K.
        • Bible K.C.
        • et al.
        2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer.
        Thyroid. 2016; 26: 1-133
        • Kuna S.K.
        • Bracic I.
        • Tesic V.
        • et al.
        Ultrasonographic differentiation of benign from malignant neck lymphadenopathy in thyroid cancer.
        J Ultrasound Med. 2006; 25 (quiz 1538-40): 1531-1537
        • Rosário P.W.S.
        • de Faria S.
        • Bicalho L.
        • et al.
        Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma.
        J Ultrasound Med. 2005; 24: 1385-1389
        • Jiang L.
        • Lee C.Y.
        • Sloan D.A.
        • et al.
        Variation in the quality of thyroid nodule evaluations before surgical referral.
        J Surg Res. 2019; 244: 9-14
        • Zhao H.
        • Li H.
        Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: diagnosis of central and lateral compartment nodal metastases.
        Eur J Radiol. 2019; 112: 14-21
        • Lee C.Y.
        • Snyder S.K.
        • Lairmore T.C.
        • et al.
        Utility of surgeon-performed ultrasound assessment of the lateral neck for metastatic papillary thyroid cancer.
        J Oncol. 2012; 2012: 973124
        • Choi J.S.
        • Kim J.
        • Kwak J.Y.
        • et al.
        Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT.
        AJR Am J Roentgenol. 2009; 193: 871-878
        • Lesnik D.
        • Cunnane M.E.
        • Zurakowski D.
        • et al.
        Papillary thyroid carcinoma nodal surgery directed by a preoperative radiographic map utilizing CT scan and ultrasound in all primary and reoperative patients.
        Head Neck. 2014; 36: 191-202
        • Stack B.C.
        • Ferris R.L.
        • Goldenberg D.
        • et al.
        American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer.
        Thyroid. 2012; 22: 501-508
        • Kahramangil B.
        • Kose E.
        • Donmez M.
        • et al.
        Thyroglobulin washout from cervical lymph node fine needle aspiration biopsies in patients with differentiated thyroid cancer: an analysis of different expressions to use in post-total thyroidectomy follow-up.
        Surgery. 2020; 167: 34-39
        • Park J.H.
        • Lee Y.S.
        • Kim B.W.
        • et al.
        Skip lateral neck node metastases in papillary thyroid carcinoma.
        World J Surg. 2012; 36: 743-747
      2. Tuttle M, Morris LF, Haugen B, et al. Thyroid-differentiated and anaplastic carcinoma (Chapter 73). In: Amin MB, Edge SB, Greene F, et al. AJCC Cancer Staging Manual, 8th edition. New York: Springer International Publishing; 2017.

        • Gambardella C.
        • Tartaglia E.
        • Nunziata A.
        • et al.
        Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients.
        World J Surg Oncol. 2016; 14: 247
        • Calò P.G.
        • Pisano G.
        • Medas F.
        • et al.
        Total thyroidectomy without prophylactic central neck dissection in clinically node-negative papillary thyroid cancer: is it an adequate treatment?.
        World J Surg Oncol. 2014; 12: 152
        • Gan T.
        • Huang B.
        • Chen Q.
        • et al.
        Risk of recurrence in differentiated thyroid cancer: a population-based comparison of the 7th and 8th editions of the American joint committee on cancer staging systems.
        Ann Surg Oncol. 2019; 26: 2703-2710
        • Sippel R.S.
        • Robbins S.E.
        • Poehls J.L.
        • et al.
        A randomized controlled clinical trial no clear benefit to prophylactic central neck dissection in patients with clinically node negative papillary thyroid cancer.
        Ann Surg. 2020; 272: 496-503
        • Wells S.A.
        • Asa S.L.
        • Dralle H.
        • et al.
        Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
        Thyroid. 2015; 25: 567-610
        • Hughes D.T.
        • Laird A.M.
        • Miller B.S.
        • et al.
        Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
        Ann Surg Oncol. 2012; 19: 2951-2957
        • Clayman G.L.
        • Agarwal G.
        • Edeiken B.S.
        • et al.
        Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma.
        Thyroid. 2011; 21: 1309-1316
        • Tufano R.P.
        • Bishop J.
        • Wu G.
        Reoperative central compartment dissection for patients with recurrent/persistent papillary thyroid cancer: efficacy, safety, and the association of the BRAF mutation.
        Laryngoscope. 2012; 122: 1634-1640
        • Giordano D.
        • Valcavi R.
        • Thompson G.B.
        • et al.
        Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature.
        Thyroid. 2012; 22: 911-917
        • Fan C.
        • Zhou X.
        • Su G.
        • et al.
        Risk factors for neck hematoma requiring surgical re-intervention after thyroidectomy: a systematic review and meta-analysis.
        BMC Surg. 2019; 19: 98
        • Chéreau N.
        • Buffet C.
        • Trésallet C.
        • et al.
        Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: predictive factors and operative management.
        Surgery. 2016; 159: 755-762
        • Barczyński M.
        • Konturek A.
        • Stopa M.
        • et al.
        Nodal recurrence in the lateral neck after total thyroidectomy with prophylactic central neck dissection for papillary thyroid cancer.
        Langenbecks Arch Surg. 2014; 399: 237-244
        • Ryu I.S.
        • Song C.I.
        • Choi S.-H.
        • et al.
        Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.
        Ann Surg Oncol. 2014; 21: 277-283
        • Lee H.S.
        • Roh J.-L.
        • Gong G.
        • et al.
        Risk factors for re-recurrence after first reoperative surgery for locoregional recurrent/persistent papillary thyroid carcinoma.
        World J Surg. 2015; 39: 1943-1950
        • Yim J.H.
        • Kim W.B.
        • Kim E.Y.
        • et al.
        The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation.
        J Clin Endocrinol Metab. 2011; 96: 2049-2056
        • Machens A.
        • Dralle H.
        Surgical cure rates of sporadic medullary thyroid cancer in the era of calcitonin screening.
        Eur J Endocrinol. 2016; 175: 219-228
        • Miyauchi A.
        • Matsuzuka F.
        • Hirai K.
        • et al.
        Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations.
        World J Surg. 2002; 26: 1023-1028
        • Liu F.-H.
        • Kuo S.-F.
        • Hsueh C.
        • et al.
        Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
        J Surg Oncol. 2015; 112: 149-154
        • Medas F.
        • Canu G.L.
        • Boi F.
        • et al.
        Predictive factors of recurrence in patients with differentiated thyroid carcinoma: a retrospective analysis on 579 patients.
        Cancers (Basel). 2019; 11: 1230
        • Hughes D.T.
        • Miller B.S.
        • Cohen M.S.
        • et al.
        Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
        Ann Surg Oncol. 2014; 21: 1647-1652
        • O’Neill C.J.
        • Coorough N.
        • Lee J.C.
        • et al.
        Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases.
        ANZ J Surg. 2014; 84: 240-244